Background: Programs targeting serodiscordant couples in Africa are not a priority in efforts to prevent Human Immunodeficiency Virus (HIV) infection, although a large proportion of these occur in stable relationships, of which serodiscordance accounts for about two-thirds with a high risk of seroconversion of the seronegative partner. Objective: The objective of this study was to describe the profile of HIV serodiscordant couples followed in Kinshasa, DRC. Methods: Descriptive cross-sectional study to describe the profile of different heterosexual HIV serodiscordant couples followed at the Monkole Medical Center in Kinshasa, DRC, from November 2021 to June 2022. The data were collected from the information sheets elaborated by the research team as well as from the information provided by the computerized files of the patients managed at the Infectious Diseases Unit of the Monkole Medical Center after the signature of the informed consent. An average of 8 cc of blood was taken from a peripheral vein in the patient’s forearm, and was stored in EDTA tubes at −20˚C, of which at least 6 mL were used for biochemical analyses, 2 spots of 200 μL for each partner were stored on filter paper at −20˚C and were used for DNA extraction. Nested PCR confirmed the serological diagnosis. Results: Out of a total of 482 heterosexual couples followed for HIV at the Monkole Medical Center, 28 (5.8%) were HIV serodiscordant, of which 14 (2.9%) couples agreed to participate in the present study. The mean age was 43.39 ± 10 years with extremes ranging from 24 to 62 years. The patients were mainly from the informal sector (53.6%) and weighed between 61 and 71 kg (46.4%). Sexual intercourse continued in all couples, without condom use (85.7%) for desire of procreation (82.1%); although the great majority of HIV-negative partners (85.7%) were not under ARV prophylaxis. Leukopenia was found in 42.9% of HIV-negative partners compared to 21% of HIV-positive partners; all partners had a predominantly lymphocytic white blood cell count. 21.4% of
References
[1]
ONUSIDA: Joint United Nations Programme on HIV/AIDS (2021) Fiche d’information—Dernières statistiques mondiales sur l’état de l’épidémie de sida. Genève. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_fr.pdf
[2]
Chomba, E., Allen, S., Kanweka, W., Tichacek, A., Cox, G., Shutes, E., et al. (2008) Evolution of Couples’ Voluntary Counseling and Testing for HIV in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47, 108-115. https://doi.org/10.1097/QAI.0b013e31815b2d67
[3]
Malamba, S.S., Mermin, J.H., Bunnell, R., Mubangizi, J., Kalule, J., Marum, E., et al. (2005) Couples at Risk: HIV-1 Concordance and Discordance among Sexual Partners Receiving Voluntary Counseling and Testing in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39, 576-580.
[4]
Chemaitelly, H., Awad, S.F. and Abu-Raddad, L.J. (2014) The Risk of HIV Transmission within HIV-1 Sero-Discordant Couples Appears to Vary across Sub-Saharan Africa. Epidemics, 6, 1-9. https://doi.org/10.1016/j.epidem.2013.11.001
[5]
Bunnell, R., Mermin, J. and De Cock, K.M. (2006) HIV Prevention for a Threatened Continent: Implementing Positive Prevention in Africa. The Journal of the American Medical Association, 296, 855-858. https://doi.org/10.1001/jama.296.7.855
[6]
Pontillo, A., Da Silva, R.C., Moura, R. and Crovella, S. (2014) Host Genomic HIV Restriction Factors Modulate the Response to Dendritic Cell-Based Treatment against HIV-1. Human Vaccines & Immunotherapeutics, 10, 512-518. https://doi.org/10.4161/hv.27125
[7]
Danboyi, D.A. (2022) Molecular Detection of CCR5 D32 Allele Gene among Discordant HIV-Infected Couples in Kaduna State, Nigeria. https://doi.org/10.21203/rs.3.rs-1292860/v1
[8]
Carpenter, L.M., Kamali, A., Ruberantwari, A., Malamba, S.S. and Whitworth, J.A.G. (1999) Rates of HIV-1 Transmission within Marriage in Rural Uganda in Relation to the HIV Sero-Status of the Partners. AIDS, 13, 1083-1089. https://journals.lww.com/aidsonline/Fulltext/1999/06180/Rates_of_HIV_1_transmission_within_marriage_in.12.aspx
[9]
Matovu, J.K.B. (2010) Preventing HIV Transmission in Married and Cohabiting HIV-Discordant Couples in Sub-Saharan Africa through Combination Prevention. Current HIV Research, 8, 430-440. https://doi.org/10.2174/157016210793499303
[10]
Curran, K., Baeten, J.M., Coates, T.J., Kurth, A., Mugo, N.R. and Celum, C. (2012) HIV-1 Prevention for HIV-1 Serodiscordant Couples. Current HIV/AIDS Reports, 9, 160-170. https://doi.org/10.1007/s11904-012-0114-z
[11]
Onovo, A.A., Nta, I.E., Onah, A.A., Okolo, C.A., Aliyu, A., Dakum, P., et al. (2015) Partner HIV Serostatus Disclosure and Determinants of Serodiscordance among Prevention of Mother to Child Transmission Clients in Nigeria. BMC Public Health, 15, Article No. 827. https://doi.org/10.1186/s12889-015-2155-x
[12]
Bunnell, R.E., Nassozi, J., Marum, E., Mubangizi, J., Malamba, S., Dillon, B., et al. (2005) Living with Discordance: Knowledge, Challenges, and Prevention Strategies of HIV-Discordant Couples in Uganda. AIDS Care, 17, 999-1012. https://doi.org/10.1080/09540120500100718
[13]
Desgrées-du-Loû, A. and Orne-Gliemann, J. (2008) Couple-Centred Testing and Counselling for HIV Serodiscordant Heterosexual Couples in Sub-Saharan Africa. Reproductive Health Matters, 16, 151-161. https://doi.org/10.1016/S0968-8080(08)32407-0
[14]
Kaiser, R., Bunnell, R., Hightower, A., Kim, A.A., Cherutich, P., Mwangi, M., et al. (2011) Factors Associated with HIV Infection in Married or Cohabitating Couples in Kenya: Results from a Nationally Representative Study. PLOS ONE, 6, e17842. https://doi.org/10.1371/journal.pone.0017842
[15]
Tadesse, M. (2014) Assessment of HIV Discordance and Associated Risk Factors among Couples Receiving HIV Test in Dilla, Ethiopia. BMC Research Notes, 7, Article No. 893. https://doi.org/10.1186/1756-0500-7-893
[16]
De Walque, D. (2007) Sero-Discordant Couples in Five African Countries: Implications for Prevention Strategies. Population and Development Review, 33, 501-523. https://doi.org/10.1111/j.1728-4457.2007.00182.x
[17]
Gokaba, J.M. (2020) Sérologie discordante du VIH/sida et vie des couples en République du Congo: Profil sociodémographique, comportements, facteurs de survie et prise en charge. https://theses.hal.science/tel-03160588/
[18]
Habte, E., Yami, A., Alemseged, F., Abdissa, Y., Deribe, K., Memiah, P., et al. (2015) Predictors of HIV Serodiscordance among Couples in Southwestern Ethiopia. Journal of the International Association of Providers of AIDS Care (JIAPAC), 14, 234-240. https://doi.org/10.1177/2325957413488177
[19]
Osinde, M.O., Kaye, D.K. and Kakaire, O. (2011) Sexual Behaviour and HIV Sero-Discordance among HIV Patients Receiving HAART in Rural Uganda. Journal of Obstetrics and Gynaecology, 31, 436-440. https://doi.org/10.3109/01443615.2011.578228
[20]
Lingappa, J.R., Lambdin, B., Bukusi, E.A., Ngure, K., Kavuma, L., Inambao, M., et al. (2008) Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial. PLOS ONE, 3, e1411. https://doi.org/10.1371/journal.pone.0001411
[21]
Takassi, O.E., Akolly, D.A.E., Guedenon, K.M. and Atakouma, Y.D. (2020) Partage du statut serologique au sein des couples serodiscordants dans un protocole de PTME en pediatrie au CHU Sylvanus Olympio (Togo). Journal de la Recherche Scientifique de l’Université de Lomé, 22, 243-248.
[22]
Guira, O., Tieno, H., Sawadogo, S. and Drabo, J.Y. (2013) Sexuality and Risk for Sexual Transmission of HIV among Serodiscordant Couples in Ouagadougou, Burkina Faso. Bulletin de la Société de pathologie exotique, 106, 43-47. https://doi.org/10.1007/s13149-012-0271-8
[23]
Smith, K.P. and Watkins, S.C. (2005) Perceptions of Risk and Strategies for Prevention: Responses to HIV/AIDS in Rural Malawi. Social Science & Medicine, 60, 649-660. https://doi.org/10.1016/j.socscimed.2004.06.009
[24]
Fauci, A.S. (2008) Human Immunodeficiency Virus Disease: AIDS and Related Disease. In: Jameson, J., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L. and Loscalzo, J., Eds., Harrison’s Principles of Internal Medicine, McGraw Hill, New York, 1137-1204.
[25]
Kairania, R., Gray, R.H., Kiwanuka, N., Makumbi, F., Sewankambo, N.K., Serwadda, D., et al. (2010) Disclosure of HIV Results among Discordant Couples in Rakai, Uganda: A Facilitated Couple Counselling Approach. AIDS Care, 22, 1041-1051. https://doi.org/10.1080/09540121003602226
[26]
Galvin, S.R. and Cohen, M.S. (2004) The Role of Sexually Transmitted Diseases in HIV Transmission. Nature Reviews Microbiology, 2, 33-42. https://doi.org/10.1038/nrmicro794
[27]
Lau, C. and Muula, A.S. (2004) HIV/AIDS in Sub-Saharan Africa. Croatian Medical Journal, 45, 402-414.
[28]
Guthrie, B.L., de Bruyn, G. and Farquhar, C. (2007) HIV-1-Discordant Couples in Sub-Saharan Africa: Explanations and Implications for High Rates of Discordancy. Current HIV Research, 5, 416-429. https://doi.org/10.2174/157016207781023992
[29]
N’Gbichi, J.M., De Cock, K.M., Batter, V., Yeboue, K., Ackah, A., Zadi, F., et al. (1995) HIV Status of Female Sex Partners of Men Reactive to HIV-1, HIV-2 or Both Viruses in Abidjan, Côte D’ivoire. AIDS, 9, 951-954. https://doi.org/10.1097/00002030-199508000-00018
[30]
Bros, B., Leblanc, T., Barbier-Bouvet, B., Beytout, J., Casassus, P. and Danjou, G. (1997) Lecture Critique de l’hémogramme: Valeurs seuils à reconnaître comme probablement pathologiques et principales variations non pathologiques. Natl Agency Accredit Eval Heal, 1-37. https://www.has-sante.fr/upload/docs/application/pdf/Hemogram.pdf
[31]
Wuillemin, T., Sami, K., Favrod-Coune, T. and Bragança IG, A.D.S. (2017) Anémie, Hopitaux Universitaires de Genève. Département de médecine communautaire, de premier recours et des urgences, Service de médecine de premier recours. 1-36.
[32]
OMS: Organisation mondiale de la Santé (2011) Concentrations en hémoglobine permettant de diagnostiquer l’anémie et d’en évaluer la sévérité. Système d’informations nutritionnelles sur les vitamines et les minéraux. (WHO/NMH/NHD/MNM/11.1). Genève.
[33]
Shearer, G.M. and Clerici, M. (1996) Protective Immunity against HIV Infection: Has Nature Done the Experiment for Us? Immunology Today, 17, 21-24. https://doi.org/10.1016/0167-5699(96)80564-0
[34]
Bentwich, Z., Kalinkovich, A. and Weisman, Z. (1995) Immune Activation Is a Dominant Factor in the Pathogenesis of African AIDS. Immunology Today, 16, 187-191. https://doi.org/10.1016/0167-5699(95)80119-7
[35]
Jennes, W., Sawadogo, S., Koblavi-Deme, S., Vuylsteke, B., Maurice, C., Roels, T.H., et al. (2003) Cellular Human Immunodeficiency Virus (HIV)—Protective Factors: A Comparison of HIV-Exposed Seronegative Female Sex Workers and Female Blood Donors in Abidjan, Coôte d’Ivoire. The Journal of Infectious Diseases, 187, 206-214. https://doi.org/10.1086/346049
[36]
Truong, L.X., Luong, T.T., Scott-Algara, D., Versmisse, P., David, A., Perez-Bercoff, D., et al. (2003) CD4 Cell and CD8 Cell-Mediated Resistance to HIV-1 Infection in Exposed Uninfected Intravascular Drug Users in Vietnam. AIDS, 17, 1425-1434. https://doi.org/10.1097/00002030-200307040-00002
[37]
Skurnick, J.H., Palumbo, P., DeVico, A., Shacklett, B.L., Valentine, F.T., Merges, M., et al. (2002) Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure. The Journal of Infectious Diseases, 185, 428-438. https://doi.org/10.1086/338830
[38]
Yang, O.O., Boscardin, W.J., Matud, J., Hausner, M.A., Hultin, L.E., Hultin, P.M., et al. (2002) Immunologic Profile of Highly Exposed yet HIV Type 1-Seronegative Men. AIDS Research and Human Retroviruses, 18, 1051-1065. https://doi.org/10.1089/08892220260235416
[39]
Bonnard, P., Guiard-Schmid, J.B. and Pialoux, G. (2005) Principes des traitements des patients infectés par le VHI. Antibiotiques, 7, 77-86. https://doi.org/10.1016/S1294-5501(05)80171-2
[40]
Berre, S., Gaudin, R., Cunha de Alencar, B., Desdouits, M., Chabaud, M., Naffakh, N., et al. (2013) CD36-Specific Antibodies Block Release of HIV-1 from Infected Primary Macrophages and Its Transmission to T Cells. Journal of Experimental Medicine, 210, 2523-2538. https://doi.org/10.1084/jem.20130566
[41]
Strain, M.C., Little, S.J., Daar, E.S., Havlir, D.V., Günthard, H.F., Lam, R.Y., et al. (2005) Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1. The Journal of Infectious Diseases, 191, 1410–1418. https://doi.org/10.1086/428777
[42]
Ngo-Giang-Huong, N., Deveau, C., Da Silva, I., Pellegrin, I., Venet, A., Harzic, M., et al. (2001) Proviral HIV-1 DNA in Subjects Followed since Primary HIV-1 Infection Who Suppress Plasma Viral Load after One Year of Highly Active Antiretroviral Therapy. AIDS, 15, 665-673. https://doi.org/10.1097/00002030-200104130-00001
[43]
Eisele, E. and Siliciano, R.F. (2012) Redefining the Viral Reservoirs That Prevent HIV-1 Eradication. Immunity, 37, 377-388. https://doi.org/10.1016/j.immuni.2012.08.010
[44]
Geeraert, L., Kraus, G. and Pomerantz, R.J. (2008) Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection. Annual Review of Medicine, 59, 487-501. https://doi.org/10.1146/annurev.med.59.062806.123001
[45]
Dormont, J. and Aboulker, J.P. (1994) Les traitements antirétroviraux dans l’infection par le virus de l’immunodéficience humaine (VIH). La Revue du Praticien, 44, 1635-1642.
[46]
van der Steeg, W.A., Boekholdt, S.M., Stein, E.A., El-Harchaoui, K., Stroes, E.S.G., Sandhu, M.S., et al. (2007) Role of the Apolipoprotein B—Apolipoprotein AI Ratio in Cardiovascular Risk Assessment: A Case-Control Analysis in EPIC-Norfolk. Annals of Internal Medicine, 146, 640-648. https://doi.org/10.7326/0003-4819-146-9-200705010-00007
[47]
Sadeghpour, S., Khodaee, S., Rahnama, M., Rahimi, H. and Ebrahimi, D. (2021) Human APOBEC3 Variations and Viral Infection. Viruses, 13, Article 1366. https://doi.org/10.3390/v13071366
[48]
Stavrou, S. and Ross, S.R. (2015) APOBEC3 Proteins in Viral Immunity. The Journal of Immunology, 195, 4565-4570. https://doi.org/10.4049/jimmunol.1501504
[49]
Drame, M. (2010) Hypercholestérolémie au cours du traitement antirétroviral au CESAC de Bamako. https://bibliosante.ml/bitstream/handle/123456789/9466/10M561.pdf?sequence=1&isAllowed=y
[50]
Knox, J., Boyd, A., Matser, A., Heijman, T., Sandfort, T. and Davidovich, U. (2020) Types of Group Sex and Their Association with Different Sexual Risk Behaviors among HIV-Negative Men Who Have Sex with Men. Archives of Sexual Behavior, 49, 1995-2003. https://doi.org/10.1007/s10508-020-01744-5
[51]
Passaro, R.C., Castañeda-Huaripata, A., Gonzales-Saavedra, W., Chavez-Gomez, S., Segura, E.R., Lake, J.E., et al. (2019) Contextualizing Condoms: A Cross-Sectional Study Mapping Intersections of Locations of Sexual Contact, Partner Type, and Substance Use as Contexts for Sexual Risk Behavior among MSM in Peru. BMC Infectious Diseases, 19, Article No. 958. https://doi.org/10.1186/s12879-019-4517-y
[52]
Detsis, M., Tsioutis, C., Karageorgos, S.A., Sideroglou, T., Hatzakis, A. and Mylonakis, E. (2017) Factors Associated with HIV Testing and HIV Treatment Adherence: A Systematic Review. Current Pharmaceutical Design, 23, 2568-2578. https://doi.org/10.2174/1381612823666170329125820
[53]
Yombi, J.C. and Mertes, H. (2018) Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives. AIDS Reviews, 20, 131-140. https://doi.org/10.24875/AIDSRev.M18000024
